Following a Moving Target: Advances in PSMA Radioligand Therapy for Prostate Cancer
Webcast
0.75 AMA PRA Category 1 Credit™ ...OVERVIEW
Following a Moving Target: Advances in PSMA Radioligand Therapy for Prostate Cancer is organized by Efficient LLC.
Course Opens: 12/31/2025
Course Expires: 01/01/2027
Description:
The landscape of metastatic castration-resistant prostate cancer (mCRPC) continues to rapidly evolve. One of the more transformative developments in this area has been the emergence of PSMA-directed radioligand therapy (RLT), built on the foundation of highly sensitive PSMA PET imaging. These advances offer new opportunities for more precise disease assessment and targeted treatment but also introduce important questions regarding their practical integration.
To this end, this activity is designed to support clinicians in applying contemporary data on PSMA PET and RLT to the care of their patients with mCRPC. Real patient cases anchor a discussion among community- and academic-based oncologists focused on patient selection, therapeutic sequencing, toxicity monitoring/management, and multidisciplinary coordination. Each case presentation is supported by published evidence and faculty experience to demonstrate how emerging science can be translated into clinical practice.
Learning Objectives:
- Analyze the role of PSMA-PET as a prognostic tool in PC to improve treatment selection and sequencing for patients with advanced disease
- Evaluate the application and clinical efficacy of PSMA-targeted RLTs in chemotherapy-exposed and chemotherapy-naïve mCRPC to improve identification of patients that may benefit from this modality
- Apply multidisciplinary strategies for recognizing and managing toxicities associated with PSMA-targeted RLTs to improve patient experience and long-term outcomes
ACCREDITATION & CREDITS
Credits:
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by CME Outfitters, LLC, and Efficient, LLC. CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement:
Physician Continuing Education (ACCME):
CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development (ANCC):
This activity is designated 0.75 contact hours.
Physician Associates (AAPA):
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until the program expiration date. PAs should only claim credit commensurate with the extent of their participation.
Pharmacy Continuing Education (ACPE):
This application-based activity is approved for 0.75 contact hours (0.075 CEUs) of continuing pharmacy credit.
Other Healthcare Professionals:
A Certificate of Participation will be given upon completion of the enduring activity enabling participants to register their credit with the appropriate licensing boards or associations.
TARGET AUDIENCE
PhysicianPharmacistPhysician AssistantOncologistsUrologistsNurse PractitionersRadiation OncologistsProsthetistsSPECIALITIES
OncologyProsthetics
Download eMedEvents Mobile App
Track your CE certificates and CME requirements anytime, anywhere.
RELATED ONLINE COURSES
May 16, 2022 - Nov 30, 2026 | Webcast
State required course for Tennessee
40.25 AMA PRA Category 1 Credits™
...
...
May 16, 2022 - Nov 30, 2026 | Webcast
State required course for Illinois
32 AMA PRA Category 1 Credits™
...
...
Quick Links